Office-Based Ureteroscopy Utilizing a Single Use Digital, Flexible Ureteroscope for Upper Tract Urothelial Carcinoma

NCT07630155 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2026-07-10

No results posted yet for this study

Summary

This clinical trial tests how well office based ureteroscopy utilizing a single use digital, flexible ureteroscope works for the assessment of upper tract urothelial carcinoma. Ureteroscopy is a procedure in which a thin camera called a ureteroscope is used to assess patients with a known or suspected diagnosis of upper tract urothelial carcinoma. Ureteroscopy is traditionally performed in an operating room under general anesthesia. In this study, patients undergo ureteroscopy in the doctor's office using an ultra-thin ureteroscope, which is the narrowest instrument of its kind. Because of its small size, researchers believe this procedure can be completed in the office with minimal discomfort and high patient satisfaction, which may eliminate the risks of general anesthesia and reduce delays to diagnosis. Office based ureteroscopy utilizing a single use digital, flexible ureteroscope may be effective for the assessment of upper tract urothelial carcinoma.

Conditions

  • Renal Pelvis and Ureter Urothelial Carcinoma

Interventions

DRUG

Analgesic Agent

Given PO

OTHER

Electronic Health Record Review

Ancillary studies

DRUG

Lidocaine Topical

Given intraurethrally

DEVICE

Medical Device Usage and Evaluation

Undergo ureteroscopy using 6.3 Fr single use digital ureteroscope

OTHER

Survey Administration

Ancillary studies

PROCEDURE

Ureteroscopy

Undergo ureteroscopy

Sponsors & Collaborators

  • Shenzhen HugeMed Medical Technical Development

    collaborator UNKNOWN
  • University of Michigan Rogel Cancer Center

    lead OTHER

Principal Investigators

  • Khurshid Ghani, MD · University of Michigan Rogel Cancer Center

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-31
Primary Completion
2027-08-31
Completion
2027-08-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07630155 on ClinicalTrials.gov